Page last updated: 2024-11-04

trimetaphosphoric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

trimetaphosphoric acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cyclotriphosphoric acid : The cyclic anhydride of triphosphoric acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID510
CHEMBL ID1620743
CHEBI ID16517
MeSH IDM0053875

Synonyms (16)

Synonym
CHEBI:16517 ,
cyclotriphosphoric acid
C02466
13566-25-1
cyclo-triphosphoric acid
trimetaphosphoric acid
1,3,5,2,4,6-trioxatriphosphinane-2,4,6-triol 2,4,6-trioxide
metaphosphoric acid (h3p3o9)
h6c6t4285h ,
unii-h6c6t4285h
2,4,6-trihydroxy-, 2,4,6-trioxide
CHEMBL1620743
DTXSID40159485
AKOS030228599
2,4,6-trihydroxy-1,3,5,2lambda5,4lambda5,6lambda5-trioxatriphosphinane 2,4,6-trioxide
trihydroxy-1,3,5,2|e?,4|e?,6|e?-trioxatriphosphinane-2,4,6-trione

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Our results demonstrate that such a system indeed improves the relative oral bioavailability of exenatide to a level of about 77% compared to subcutaneous injection due to the presence of dextran in the coating wall of the NPs which apparently promotes the lymphatic uptake in the enterocytes."( Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach.
Benita, S; Naraykin, N; Nassar, T; Soudry-Kochavi, L, 2015
)
0.42

Dosage Studied

ExcerptRelevanceReference
"05) and dose-response relationship between treatments."( Anticaries effect of dentifrices with calcium citrate and sodium trimetaphosphate.
Bergamaschi, M; Delbem, AC; Missel, EM; Rodrigues, E; Sassaki, KT; Vieira, AE, 2012
)
0.38
" A dose-response was observed between fluoride concentration in toothpastes and fluoride present in enamel, regardless of dilution."( In vitro enamel remineralization by low-fluoride toothpaste with calcium citrate and sodium trimetaphosphate.
Danelon, M; Delbem, AC; Freire, IR; Hirata, E, 2013
)
0.39
" A dose-response relationship was observed between fluoride concentrations in the varnishes and %SHR."( In vitro remineralizing effect of fluoride varnishes containing sodium trimetaphosphate.
Castilho, FC; Delbem, AC; Lima, TM; Manarelli, MM; Pessan, JP, 2014
)
0.4
" No dose-response relationship was found between TMP concentration and wear and hardness."( Effect of fluoride varnish supplemented with sodium trimetaphosphate on enamel erosion and abrasion.
Delbem, AC; Manarelli, MM; Martinhon, CC; Moretto, MJ; Pessan, JP; Sassaki, KT, 2013
)
0.39
"A dose-response relationship was verified between F concentrations in the dentifrices and in the biofilm fluid."( Fluoride and calcium concentrations in the biofilm fluid after use of fluoridated dentifrices supplemented with polyphosphate salts.
Buzalaf, MA; Delbem, AC; Hall, KB; Nagata, ME; Pessan, JP, 2017
)
0.46
"We observed a dose-response relation between F concentrations in the gels without TMP for %SHR and ΔKHN."( Effect of fluoride gels with nano-sized sodium trimetaphosphate on the in vitro remineralization of caries lesions.
Báez-Quintero, LC; Danelon, M; Delbem, ACB; Monteiro, DR; Nagata, ME; Pessan, JP; Sampaio, C; Wiegand, A, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
phosphorus oxoacidA pnictogen oxoacid which contains phosphorus and oxygen, at least one hydrogen atom bound to oxygen, and forms an ion by the loss of one or more protons.
inorganic heterocyclic compound
cyclic phosphorus acid anhydride
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (143)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (6.99)18.7374
1990's12 (8.39)18.2507
2000's16 (11.19)29.6817
2010's73 (51.05)24.3611
2020's32 (22.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.65 (24.57)
Research Supply Index5.08 (2.92)
Research Growth Index5.37 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials13 (8.90%)5.53%
Reviews4 (2.74%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other129 (88.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]